Metastatic adenocarcinoma found in inguinal, pelvic and para-aortic lymph nodes 14years following hysterectomy for adenocarcinoma in situ of the cervix

Gynecologic Oncology Reports

Volumn 2, Issue 3, 2012, Pages 97-99

  Costales, Anthony B ^a   Eifel, Patricia J ^a   Deavers, Michael T ^a   Frumovitz, Michael ^a   Schmeler, Kathleen M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adenocarcinoma; Adenocarcinoma in situ; Cervix

Indexed keywords

CARBOPLATIN; CYTOKERATIN 18; CYTOKERATIN 7; CYTOKERATIN 8; ESTROGEN RECEPTOR; PACLITAXEL; PROTEIN P16; TRANSCRIPTION FACTOR PAX8;

ADENOCARCINOMA; ADULT; ARTICLE; CASE REPORT; CERVIX ADENOCARCINOMA; COLONOSCOPY; COLPOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; INGUINAL ADENOCARCINOMA; INTENSITY MODULATED RADIATION THERAPY; LEG EDEMA; LYMPHADENOPATHY; METASTASIS POTENTIAL; MULTIPLE CYCLE TREATMENT; PARAAORTIC LYMPH NODE; PELVIC ADENOCARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 84864014170     PISSN: None     EISSN: 2211338X     Source Type: Journal    
DOI: 10.1016/j.gynor.2012.05.001     Document Type: Article

References (11)

1. Bull-Phelps S.L., Garner E.I., Walsh C.S., Gehrig P.A., Miller D.S., Schorge J.O. Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix. Gynecol. Oncol. 2007, 107(2):316-319. (Nov).
2. Hopkins M.P., Roberts J.A., Schmidt R.W. Cervical adenocarcinoma in situ. Obstet. Gynecol. 1988, 71:842-844.
3. Im D.D., Duska L.R., Rosenshein N.B. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease. Gynecol. Oncol. 1995, 59(2):179-182. (Nov).
4. Krivak T.C., Retherford B., Voskuil S., Rose G.S., Alagoz T. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ. Gynecol. Oncol. 2000, 77(2):334-335. (May).
5. McHale M.T., Le T.D., Burger R.A., Gu M., Rutgers J.L., Monk B.J. Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix. Obstet. Gynecol. 2001, 98(5 Pt 1):726-731. (Nov).
6. Miller B., Dunn J., Dalrymple J., Krivak T.C. Pelvic sidewall adenocarcinoma after definitive therapy for cervical adenocarcinoma in situ. Gynecol. Oncol. 2005, 99(2):489-492. (Nov).
7. Ostor A.G., Duncan A., Quinn M., Rome R. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases. Gynecol. Oncol. 2000, 79(2):207-210. (Nov).
8. Salani R., Puri I., Bristow R.E. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status. Am. J. Obstet. Gynecol. 2009, 200:182.e1-182.e5.
9. Shin C.H., Schorge J.O., Lee K.R., Sheets E.E. Conservative management of adenocarcinoma in situ of the cervix. Gynecol. Oncol. 2000, 79(1):6-10. (Oct).
10. Wolf J.K., Levenback C., Malpica A., Morris M., Burke T., Mitchell M.F. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins. Obstet. Gynecol. 1996, 88(1):82-86. (Jul).
11. Wright T.C., Massad S.L., Dunton C.J., et al. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am. J. Obstet. Gynecol. 2007, 197:340-345.